Skip to main content

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q1 2022)
0
Sold out in Q1 2022
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q2 2021
Holdings of NTLA by Affinity Asset Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20220$00.0%−10,000−100.0%Sold outHolders
Q4 202110,000$1.18M0.5%−5,000−33.3%ReducedHolders
Q3 202115,000$2.01M0.8%+5,000+50.0%AddedHolders
Q2 202110,000$1.62M0.8%+10,000NewHolders